These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 20649631)

  • 21. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
    Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
    Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A work in progress: the metabolic syndrome.
    Luchsinger JA
    Sci Aging Knowledge Environ; 2006 Jun; 2006(10):pe19. PubMed ID: 16807483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
    Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
    J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.
    Soveri I; Abedini S; Holdaas H; Jardine A; Eriksson N; Fellström B
    Clin Transplant; 2009; 23(6):914-20. PubMed ID: 19594771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population.
    Benguigui C; Bongard V; Ruidavets JB; Chamontin B; Sixou M; Ferrières J; Amar J
    J Clin Periodontol; 2010 Jul; 37(7):601-8. PubMed ID: 20492076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
    Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
    Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study.
    Takeuchi H; Saitoh S; Takagi S; Ohnishi H; Ohhata J; Isobe T; Shimamoto K
    Hypertens Res; 2005 Mar; 28(3):203-8. PubMed ID: 16097362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and its components are underdiagnosed in cardiology clinics.
    Fujiyoshi A; Murad MH; Luna M; Rosario A; Ali S; Paniagua D; Molina J; Lopez M; Jacobs S; Lopez-Jimenez F
    J Eval Clin Pract; 2011 Feb; 17(1):78-83. PubMed ID: 20825539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular basis of metabolic syndrome: insulin resistance].
    Yamada N
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():23-9. PubMed ID: 17458190
    [No Abstract]   [Full Text] [Related]  

  • 36. [The MONK study and the CASE-J trial].
    Ueshima K; Nakao K; Moriyama K; Miyawaki T
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():83-7. PubMed ID: 21766577
    [No Abstract]   [Full Text] [Related]  

  • 37. [The current situation of newly started lifestyle intervention system to reduce metabolic syndrome in Japan--specific health checkup and health guidance].
    Tsushita K; Muramoto A
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():723-8. PubMed ID: 21766688
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of hepatic insulin resistance in pathogenesis of metabolic syndrome].
    Aizawa-Abe M
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():180-4. PubMed ID: 21766593
    [No Abstract]   [Full Text] [Related]  

  • 39. [Framingham Study].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():47-57. PubMed ID: 21766572
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin resistance in the kidney].
    Ura N; Yamagishi Y; Saitoh N
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():169-73. PubMed ID: 17458213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.